Treating Newly Diagnosed RCC Patients

Bradley McGregor MD, Instructor, Medicine, Harvard Medical School, Clinical Director, Lank Center for Genitourinary Oncology, GU Network Liaison, Dana Farber Cancer Institute considers a new approach to treating newly diagnosed renal cell carcinoma (RCC) patients.